The Lovesac Company Announces Third Quarter Conference Call Date GlobeNewswire November 26, 2025 STAMFORD, Conn., Nov. 26, 2025 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand, today announced that its third quarter financial results will be released before market open on Thursday, December […]
Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025 GlobeNewswire November 26, 2025 TUCSON, Ariz., Nov. 26, 2025 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world's first total artificial heart approved by both
Nasdaq Halts Charming Medical Limited GlobeNewswire November 26, 2025 NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) — The Nasdaq Stock Market(R) (Nasdaq: NDAQ) announced that trading is halted in Charming Medical Limited (Nasdaq: MCTA) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading suspension in MCTA from 04:00:00
OTC Markets Group Welcomes Erdene Resource Development Corp. to OTCQX GlobeNewswire November 26, 2025 NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Erdene Resource Development Corp. (TSX: ERD; OTCQX: ERDCF), a Canadian-based resource company, has qualified
Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference GlobeNewswire November 26, 2025 BOSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Adam Crystal, M.D., Ph.D., President of Research & Development at Tango Therapeutics, is scheduled to participate in a fireside chat at the Piper Sandler
CG Oncology Announces New Board Member and Board Transition GlobeNewswire November 26, 2025 – Appoints Accomplished Life Sciences Executive Christina Rossi to its Board of Directors – IRVINE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic
OTC Markets Group Welcomes GoldQuest Mining Corp. to OTCQX GlobeNewswire November 26, 2025 NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced GoldQuest Mining Corp. (TSX-V: GQC; OTCQX: GDQMF), a Canadian exploration and development company focused on
Herantis Pharma announces successful completion of six-month GLP toxicology study of HER-096 GlobeNewswire November 26, 2025 Key step achieved in advancing HER-096 towards Phase 2 efficacy trial Espoo, Finland, 26 November 2025: Herantis Pharma Plc (“Herantis”), a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson's disease, today announces the successful completion of
What Global CMOs Want in 2026: Strategic Priorities and Agency Expectations 805 international marketing leaders reveal how AI is reshaping the future of brand-building in the CMO Barometer from Serviceplan Group, University of St. Gallen, and Heidrick & Struggles GlobeNewswire November 26, 2025 Munich, Nov. 26, 2025 (GLOBE NEWSWIRE) — Based on exclusive insights from
Oncolytic Virus CDMO Services Market to Reach USD 1734.41 Million, at 15.25% CAGR by 2035 The global oncolytic virus CDMO services market size is valued at USD 419.51 million in 2025 and is predicted to hit around USD 1734.41 million by 2035, rising at a 15.25% CAGR, a study published by Towards Healthcare a sister